Lyn M. Huff

753 total citations
18 papers, 570 citations indexed

About

Lyn M. Huff is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Lyn M. Huff has authored 18 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Lyn M. Huff's work include Drug Transport and Resistance Mechanisms (12 papers), MicroRNA in disease regulation (3 papers) and DNA Repair Mechanisms (2 papers). Lyn M. Huff is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), MicroRNA in disease regulation (3 papers) and DNA Repair Mechanisms (2 papers). Lyn M. Huff collaborates with scholars based in United States, Canada and South Korea. Lyn M. Huff's co-authors include Susan E. Bates, Robert W. Robey, Kuniaki Morisaki, Tito Fojo, Kenneth K.W. To, Orsolya Polgár, Yasumasa Honjo, Jeffrey Hung, Michael Dean and Jongseok Lee and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Scientific Reports.

In The Last Decade

Lyn M. Huff

18 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lyn M. Huff United States	15	366	305	106	90	78	18	570
Seiji Doi Japan	12	511 1.4×	365 1.2×	58 0.5×	78 0.9×	177 2.3×	20	737
Kimie Kondo United States	15	259 0.7×	484 1.6×	127 1.2×	61 0.7×	65 0.8×	22	793
Joanna Regis United States	10	550 1.5×	270 0.9×	44 0.4×	160 1.8×	47 0.6×	14	660
Janice Madafiglio Australia	13	361 1.0×	460 1.5×	151 1.4×	71 0.8×	24 0.3×	18	800
Eiji Hinoshita Japan	9	514 1.4×	276 0.9×	56 0.5×	142 1.6×	61 0.8×	11	709
Olga Ujhelly Hungary	10	514 1.4×	400 1.3×	31 0.3×	113 1.3×	110 1.4×	15	759
Satish Cheepala United States	14	192 0.5×	318 1.0×	62 0.6×	42 0.5×	32 0.4×	20	549
Veronika Brynychová Czechia	14	341 0.9×	382 1.3×	246 2.3×	22 0.2×	55 0.7×	28	639
Yujia Wen United States	10	228 0.6×	359 1.2×	307 2.9×	58 0.6×	86 1.1×	28	623
Viktor Hlaváč Czechia	13	260 0.7×	280 0.9×	168 1.6×	20 0.2×	57 0.7×	35	475

Countries citing papers authored by Lyn M. Huff

Since Specialization

Citations

This map shows the geographic impact of Lyn M. Huff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyn M. Huff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyn M. Huff more than expected).

Fields of papers citing papers by Lyn M. Huff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyn M. Huff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyn M. Huff. The network helps show where Lyn M. Huff may publish in the future.

Co-authorship network of co-authors of Lyn M. Huff

This figure shows the co-authorship network connecting the top 25 collaborators of Lyn M. Huff. A scholar is included among the top collaborators of Lyn M. Huff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyn M. Huff. Lyn M. Huff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Huff, Lyn M., et al.. (2023). The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers. Cancer Drug Resistance. 6(6). 468–80. 14 indexed citations

Robey, Robert W., Lyn M. Huff, Sabrina Lusvarghi, et al.. (2021). Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter. Scientific Reports. 11(1). 24150–24150. 22 indexed citations

Chen, Kevin G., George E. Durán, Jean‐Pierre Jaffrézou, et al.. (2020). Genomic stability at the coding regions of the multidrug transporter gene ABCB1: insights into the development of alternative drug resistance mechanisms in human leukemia cells. Cancer Drug Resistance. 3. 959–979. 1 indexed citations

Fojo, Tito, Lyn M. Huff, Thomas Litman, et al.. (2020). Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape. BMC Medical Genomics. 13(1). 165–165. 19 indexed citations

Harbuzariu, Adriana, et al.. (2020). Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer. International Journal of Molecular Sciences. 21(11). 3794–3794. 19 indexed citations

Huff, Lyn M., Sachi Horibata, Robert W. Robey, Matthew D. Hall, & Michael M. Gottesman. (2019). Mycoplasma Infection Mediates Sensitivity of Multidrug-Resistant Cell Lines to Tiopronin: A Cautionary Tale. Journal of Medicinal Chemistry. 63(3). 1434–1439. 5 indexed citations

Huff, Lyn M., et al.. (2019). Coexpression of ABCB1 and ABCG2 in a Cell Line Model Reveals Both Independent and Additive Transporter Function. Drug Metabolism and Disposition. 47(7). 715–723. 19 indexed citations

Weiss, Ido D., Lyn M. Huff, Moses O. Evbuomwan, et al.. (2017). Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET. Oncotarget. 8(43). 73387–73406. 27 indexed citations

Huff, Lyn M., Dan L. Sackett, Marianne S. Poruchynsky, & Tito Fojo. (2010). Microtubule-Disrupting Chemotherapeutics Result in Enhanced Proteasome-Mediated Degradation and Disappearance of Tubulin in Neural Cells. Cancer Research. 70(14). 5870–5879. 28 indexed citations

10.

Huang, Hui, Michael E. Menefee, Maureen Edgerly, et al.. (2010). A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 16(5). 1634–1641. 34 indexed citations

11.

To, Kenneth K.W., Orsolya Polgár, Lyn M. Huff, Kuniaki Morisaki, & Susan E. Bates. (2008). Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells. Molecular Cancer Research. 6(1). 151–164. 102 indexed citations

12.

Liu, Wanqing, Xiaolin Wu, Wei Zhang, et al.. (2007). Relationship ofEGFRMutations, Expression, Amplification, and Polymorphisms to Epidermal Growth Factor Receptor Inhibitors in the NCI60 Cell Lines. Clinical Cancer Research. 13(22). 6788–6795. 57 indexed citations

13.

Huff, Lyn M., Jongseok Lee, Robert W. Robey, & Tito Fojo. (2006). Characterization of Gene Rearrangements Leading to Activation of MDR-1. Journal of Biological Chemistry. 281(48). 36501–36509. 44 indexed citations

14.

Chen, Kevin G., Yan C. Wang, Marci E. Schaner, et al.. (2005). Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line. Cancer Research. 65(20). 9388–9397. 41 indexed citations

15.

Rao, V. Koneti, Darawalee Wangsa, Robert W. Robey, et al.. (2005). Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells. Cancer Genetics and Cytogenetics. 160(2). 126–133. 21 indexed citations

16.

Huff, Lyn M., Wang Zheng, A Iglesias, Tito Fojo, & Jongseok Lee. (2005). Aberrant Transcription from an Unrelated Promoter Can Result in MDR-1 Expression following Drug Selection In vitro and in Relapsed Lymphoma Samples. Cancer Research. 65(24). 11694–11703. 21 indexed citations

17.

Morisaki, Kuniaki, Robert W. Robey, Csilla Özvegy, et al.. (2004). The Q141K single-nucleotide polymorphism impacts the transporter activity of ABCG2.. Cancer Research. 64. 570–570. 4 indexed citations

18.

Honjo, Yasumasa, Kuniaki Morisaki, Lyn M. Huff, et al.. (2002). Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1). Cancer Biology & Therapy. 1(6). 696–702. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact